Vera Therapeutics (VERA) had the highest return between January 8, 2024 and January 30, 2024 by a small-cap US stock, returning 120.9%.
| ASSET | DATE | % RETURN |
|---|---|---|
Vera Therapeutics (VERA) | 1/8/2024 - 1/30/2024 | 120.93% |
QuantaSing Group Limited American Depositary Shares (QSG) | 1/8/2024 - 1/30/2024 | 117.29% |
Clene (CLNNW) | 1/8/2024 - 1/30/2024 | 104.08% |
Y mAbs Therapeutics (YMAB) | 1/8/2024 - 1/30/2024 | 74.65% |
Edgewise Therapeutics (EWTX) | 1/8/2024 - 1/30/2024 | 72.47% |
Astria Therapeutics (ATXS) | 1/8/2024 - 1/30/2024 | 67.4% |
Real Brokerage (REAX) | 1/8/2024 - 1/30/2024 | 66.67% |
Immunome (IMNM) | 1/8/2024 - 1/30/2024 | 63% |
ADC Therapeutics (ADCT) | 1/8/2024 - 1/30/2024 | 58.13% |
Arcutis Biotherapeutics (ARQT) | 1/8/2024 - 1/30/2024 | 56.53% |
Dianthus Therapeutics (DNTH) | 1/8/2024 - 1/30/2024 | 51.44% |
Praxis Precision Medicines (PRAX) | 1/8/2024 - 1/30/2024 | 50.54% |
Amarin (AMRN) | 1/8/2024 - 1/30/2024 | 46.36% |
Oric Pharmaceuticals (ORIC) | 1/8/2024 - 1/30/2024 | 46.18% |
Kodiak Sciences (KOD) | 1/8/2024 - 1/30/2024 | 45.67% |
GH Research (GHRS) | 1/8/2024 - 1/30/2024 | 44.84% |
Intuitive Machines (LUNR) | 1/8/2024 - 1/30/2024 | 44.68% |
Cullinan Oncology LLC (CGEM) | 1/8/2024 - 1/30/2024 | 43.21% |
Innodata (INOD) | 1/8/2024 - 1/30/2024 | 43.14% |
Net Lease Office Properties (NLOP) | 1/8/2024 - 1/30/2024 | 42.69% |
Establishment Labs (ESTA) | 1/8/2024 - 1/30/2024 | 41.82% |
Tourmaline Bio (TRML) | 1/8/2024 - 1/30/2024 | 41.09% |
Kura Oncology (KURA) | 1/8/2024 - 1/30/2024 | 40.78% |
Hyliion (HYLN) | 1/8/2024 - 1/30/2024 | 39.51% |
Verastem (VSTM) | 1/8/2024 - 1/30/2024 | 38.58% |
Small-cap stocks are treated as having a market cap between $300M and $2B.
